Concepedia
Statistics
Publications
1
Citations
12
H-Index
Active since
2020
C. J. Der is an author specializing in cancer cell signaling, mek inhibition, and molecular oncology.
Publications per year
2020–2020
KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer
J. Peacock, E. D. Routh, J. J. Yeh et al. · UNC Libraries · 2020 · 12 citations · Full text
Medicine, Molecular Genetics, Oncology +17
1–1 of 1